COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation	Arrhythmias, Cardiac, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder	Recruiting	Phase 4	2026-10-01		NCT04642430

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Canadian Institutes of Health Research (CIHR)	339
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network	4
Ottawa Hospital Research Institute	121

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
CHU de Quebec - Université Laval	Laval	Canada	1
CISSS de l'Outaouais	Gatineau	Canada	1
Ciusss Nim	Montreal	Canada	1
Kingston General Hospital	Kingston	Canada	7
QEII Health Science Centre	Halifax	Canada	2
The Ottawa Hospital - General Campus	Ottawa	Canada	31
University Ottawa Heart Institute	Ottawa	Canada	1
Victoria Cardiac Arrhythmia Trials	Victoria	Canada	2